Squarepoint’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,313
Closed -$322K 3733
2021
Q2
$322K Buy
+5,313
New +$204K ﹤0.01% 2478
2019
Q4
Sell
-30,784
Closed -$767K 2936
2019
Q3
$767K Buy
30,784
+19,282
+168% +$412K 0.01% 1398
2019
Q2
$232K Buy
+11,502
New +$250K ﹤0.01% 2051
2019
Q1
Sell
-38,790
Closed -$788K 2543
2018
Q4
$788K Buy
38,790
+34,023
+714% +$928K 0.01% 1027
2018
Q3
$205K Buy
+4,767
New +$206K ﹤0.01% 1763
2018
Q2
Sell
-8,917
Closed -$430K 2174
2018
Q1
$430K Buy
8,917
+2,025
+29% +$97.2K 0.01% 1148
2017
Q4
$350K Buy
6,892
+2,542
+58% +$139K 0.01% 1411
2017
Q3
$249K Buy
+4,350
New +$217K ﹤0.01% 1272

Other funds holding LDL

Squarepoint's LDL Position: Q3 2021 in Review

Squarepoint sold out of Lydall, Inc. (LDL) in Q3 2021, closing a stake of 5,313 shares — an estimated $322K sold.

Squarepoint first reported a position in LDL in Q3 2017 and held it in 8 quarters. The position peaked at $788K in Q4 2018. 158 funds tracked by Wall St. Rank hold LDL as of Q3 2021.

  • Squarepoint reported no remaining Lydall, Inc. position as of Q3 2021 after selling out during the quarter.
  • Squarepoint sold 5,313 Lydall, Inc. shares in Q3 2021, an estimated $322K.
  • Squarepoint first reported a position in Lydall, Inc. in Q3 2017 and held it in 8 quarters.
  • Squarepoint's Lydall, Inc. position peaked at $788K in Q4 2018.
  • 158 funds tracked by Wall St. Rank held Lydall, Inc. as of Q3 2021.

Based on Squarepoint's 13F filing for Q3 2021, filed 15 Nov 2021.